InvestorsHub Logo
icon url

sspalmo

12/13/23 5:50 PM

#192315 RE: BBalllegend #192310

I have no problem with a product having different names in different sales areas. Nova in the US market is just a name, in the Latin markets it translates to "not going". I wouldn't want to buy a car that is called "Not Going".
Enzolytics does have a problem with clarity of their PRs.
The following PR reads like IPF Immune will be produced in North America, but it is not.
"Enzolytics, Inc. Announces Production and Sale in North America of “Enzolytics IPF Immune(TM)”, A New Dietary Supplement That Enhances the Immune System"
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-Announces-Production-and-Sale-in-North-America-of-Enzolytics-IPF-ImmuneTM-A-New-Dietary-Supplement-That-E?id=33763